ALLEGRA Side Effects

6244600-5 | Chromaturia, Liver Disorder
on Jun 19, 2009 Female patient from JAPAN , 40 years of age, was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia, liver disorder. Allegra dosage: . During the same period patient was treated with CELESTAMINE /01221101/ (View Celestamine /01221101/ Review and Celestamine /01221101/ Label ), IPD (View Ipd Review and Ipd Label ). Patient was hospitalized.

6243659-9 | Hallucination, Auditory, Thinking Abnormal
Patient was taking Allegra (View Usage). Patient had the following side effects: hallucination, auditory, thinking abnormal on Jun 17, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 44.00 lb, . Allegra dosage: .

6238884-7 | Pruritus
Adverse event was reported on Jun 17, 2009 by a Female patient taking Allegra (View Usage) (Dosage: 1 Tabet Daily Po) was diagnosed with multiple allergies and. Location: UNITED STATES , 38 years of age, weighting 235.0 lb, After Allegra was administered, patient had the following side effects: pruritus.

6233457-4 | Migraine
on Jun 16, 2009 Male patient from UNITED STATES , 37 years of age, weighting 180.0 lb, was diagnosed with rhinitis allergic and was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: migraine (What is migraine?). Allegra dosage: .


6220926-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Condition Aggravated, Decreased Appetite, Dyspepsia, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Lymphocyte Stimulation Test Positive
on Jun 04, 2009 Male patient from JAPAN , 60 years of age, weighting 150.8 lb, was treated with Allegra (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, condition aggravated, decreased appetite, dyspepsia, gamma-glutamyltransferase increased, hepatic function abnormal, lymphocyte stimulation test positive. Allegra dosage: . Patient was hospitalized.

6215268-9 | Crying, Extremity Contracture, Hypotonia Neonatal, Irritability, Neonatal Asphyxia, Restlessness, Somnolence
Patient was taking Allegra (View Usage). After Allegra was administered, patient had the following side effects: crying, extremity contracture, hypotonia neonatal, irritability, neonatal asphyxia, restlessness, somnolence on May 27, 2009 from JAPAN Additional patient health information: Female patient , weighting 6.66 lb, . Allegra dosage: Unk. During the same period patient was treated with LUTEONIN (Unk) (View Luteonin Review and Luteonin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), HALCION (View Halcion Review and Halcion Label ), CONTOMIN (View Contomin Review and Contomin Label ), EURODIN (4 Mg) (View Eurodin Review and Eurodin Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ). Patient was hospitalized.

6211498-0 | Decreased Appetite, Dyspepsia, Hepatic Function Abnormal, Malaise, Mixed Liver Injury, Nausea
Adverse event was reported on May 28, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 60 years of age, weighting 150.8 lb, Patient experienced the following unwanted or unexpected effects: decreased appetite, dyspepsia, hepatic function abnormal, malaise, mixed liver injury, nausea (What is nausea?). Patient was hospitalized.

6206881-3 | Blister, Eczema
on May 20, 2009 Female patient from JAPAN , 51 years of age, weighting 147.7 lb, was diagnosed with nasal congestion, hypertension and was treated with Allegra (View Usage). Patient had the following side effects: blister, eczema (What is eczema?). Allegra dosage: . During the same period patient was treated with ALLELOCK (View Allelock Review and Allelock Label ), RENIVACE (View Renivace Review and Renivace Label ), CRESTOR (View Crestor Review and Crestor Label ), ADALAT (View Adalat Review and Adalat Label ), CHLOCODEMIN (View Chlocodemin Review and Chlocodemin Label ), ANTEBATE (View Antebate Review and Antebate Label ). Patient was hospitalized.

6205946-X | Product Substitution Issue
on May 27, 2009 Female patient from UNITED STATES , weighting 118.0 lb, was diagnosed with rhinitis allergic and was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: product substitution issue. Allegra dosage: One A Day 30 Days.

6199993-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis Fulminant, Jaundice, Malaise
Patient was taking Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis fulminant, jaundice (What is jaundice?), malaise on May 13, 2009 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with hypertension and. Allegra dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ).

6199991-0 | Hepatic Function Abnormal, Jaundice, Mixed Liver Injury
Adverse event was reported on May 14, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 60 years of age, Patient had the following side effects: hepatic function abnormal, jaundice (What is jaundice?), mixed liver injury. Patient was hospitalized.

6188488-X | Erythema, Local Swelling, Off Label Use, Swelling Face
on May 07, 2009 Female patient from JAPAN , 65 years of age, was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: erythema, local swelling, off label use, swelling face. Allegra dosage: .

6183218-X | Abdominal Rigidity, Crying, Hypotonia Neonatal, Irritability, Neonatal Asphyxia, Restlessness, Somnolence
on Apr 28, 2009 Female patient from JAPAN , weighting 6.66 lb, was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal rigidity, crying, hypotonia neonatal, irritability, neonatal asphyxia, restlessness, somnolence. Allegra dosage: Unk. During the same period patient was treated with LUTEONIN (Unk) (View Luteonin Review and Luteonin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), HALCION (View Halcion Review and Halcion Label ), CONTOMIN (View Contomin Review and Contomin Label ), EURODIN (4 Mg) (View Eurodin Review and Eurodin Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ). Patient was hospitalized.

6171221-5 | Abdominal Pain Upper, Anorexia, Vomiting
Patient was taking Allegra (View Usage). Patient had the following side effects: abdominal pain upper, anorexia, vomiting on Apr 28, 2009 from UNITED STATES Additional patient health information: Female patient , child 4. years of age, weighting 40.60 lb, was diagnosed with hypersensitivity and. Allegra dosage: 1 Teaspoon 2x/day Po.

6169855-7 | Faeces Discoloured
Adverse event was reported on Apr 18, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) . Location: BRAZIL , child 1 years of age, After Allegra was administered, patient had the following side effects: faeces discoloured.

6169854-5 | Interstitial Lung Disease
on Apr 22, 2009 Female patient from JAPAN , 59 years of age, weighting 131.0 lb, was diagnosed with urticaria and was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Allegra dosage: . During the same period patient was treated with SHOSEIRYUTO (View Shoseiryuto Review and Shoseiryuto Label ), CLARITH (View Clarith Review and Clarith Label ), OPIUM ALKALOIDS AND DERIVATIVES (View Opium Alkaloids And Derivatives Review and Opium Alkaloids And Derivatives Label ), EMPYNASE /00521001/ (View Empynase /00521001/ Review and Empynase /00521001/ Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6168379-0 | Gastrointestinal Haemorrhage, Melaena
on Apr 16, 2009 Female patient from JAPAN , child 10 years of age, was treated with Allegra (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, melaena. Allegra dosage: .

6168375-3 | Affect Lability
Patient was taking Allegra (View Usage). After Allegra was administered, patient had the following side effects: affect lability on Apr 21, 2009 from JAPAN Additional patient health information: Male patient , child 7 years of age, weighting 55.12 lb, was diagnosed with rhinitis allergic and. Allegra dosage: .

6163431-8 | Intestinal Haemorrhage
Adverse event was reported on Apr 16, 2009 by a Female patient taking Allegra (View Usage) (Dosage: ) was diagnosed with urticaria and. Location: JAPAN , 44 years of age, Patient experienced the following unwanted or unexpected effects: intestinal haemorrhage.

6155505-2 | Liver Disorder
on Apr 10, 2009 Female patient from JAPAN , 46 years of age, was treated with Allegra (View Usage). Patient had the following side effects: liver disorder. Allegra dosage: Dose: 60 Mg X 1 Tablet. During the same period patient was treated with GARASONE (View Garasone Review and Garasone Label ).

6154235-0 | Blood Glucose Increased, Hepatic Function Abnormal
on Apr 10, 2009 Female patient from JAPAN , 50 years of age, was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: blood glucose increased, hepatic function abnormal. Allegra dosage: .

6149801-2 | Affect Lability
Patient was taking Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: affect lability on Apr 03, 2009 from JAPAN Additional patient health information: Male patient , child 7 years of age, weighting 55.12 lb, was diagnosed with rhinitis allergic and. Allegra dosage: . During the same period patient was treated with FLUNASE (View Flunase Review and Flunase Label ).

6147617-4 | Intestinal Haemorrhage
Adverse event was reported on Apr 02, 2009 by a Female patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 44 years of age, Patient had the following side effects: intestinal haemorrhage.

6144979-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholestatic Liver Injury, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise
on Mar 25, 2009 Male patient from JAPAN , 23 years of age, was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cholestatic liver injury, gamma-glutamyltransferase increased, hepatic function abnormal, malaise. Allegra dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6141285-3 | Brugada Syndrome
on Mar 26, 2009 Male patient from JAPAN , 53 years of age, weighting 130.1 lb, was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: brugada syndrome. Allegra dosage: . During the same period patient was treated with ALESION (View Alesion Review and Alesion Label ), HOMOCLOMIN /00357801/ (View Homoclomin /00357801/ Review and Homoclomin /00357801/ Label ), NEOMALLERMIN TR (View Neomallermin-tr Review and Neomallermin-tr Label ), TAGAMET (View Tagamet Review and Tagamet Label ). Patient was hospitalized.

6141284-1 | Interstitial Lung Disease
Patient was taking Allegra (View Usage). Patient had the following side effects: interstitial lung disease on Mar 26, 2009 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 131.0 lb, was diagnosed with urticaria and. Allegra dosage: . During the same period patient was treated with SHOSEIRYUTO (View Shoseiryuto Review and Shoseiryuto Label ), CLARITH (View Clarith Review and Clarith Label ), OPIUM ALKALOIDS AND DERIVATIVES (View Opium Alkaloids And Derivatives Review and Opium Alkaloids And Derivatives Label ), EMPYNASE /00521001/ (View Empynase /00521001/ Review and Empynase /00521001/ Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6135314-0 | Alanine Aminotransferase Increased, Cholestatic Liver Injury, Hepatic Function Abnormal, Malaise
Adverse event was reported on Mar 12, 2009 by a Female patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 19 years of age, After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, cholestatic liver injury, hepatic function abnormal, malaise.

6129709-9 | Liver Disorder
on Mar 13, 2009 Female patient from JAPAN , 46 years of age, was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder. Allegra dosage: Dose: 60 Mg X 1 Tablet.

6128459-2 | Alanine Aminotransferase Increased, Cholestatic Liver Injury, Hepatic Function Abnormal, Malaise
on Mar 12, 2009 Female patient from JAPAN , 19 years of age, was treated with Allegra (View Usage). Patient had the following side effects: alanine aminotransferase increased, cholestatic liver injury, hepatic function abnormal, malaise. Allegra dosage: .

6128454-3 | Blister, Eczema
Patient was taking Allegra (View Usage). After Allegra was administered, patient had the following side effects: blister, eczema (What is eczema?) on Mar 16, 2009 from JAPAN Additional patient health information: Female patient , 51 years of age, . Allegra dosage: . Patient was hospitalized.

6126362-5 | Brugada Syndrome
Adverse event was reported on Mar 16, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 56 years of age, Patient experienced the following unwanted or unexpected effects: brugada syndrome. During the same period patient was treated with ALESION (View Alesion Review and Alesion Label ), HOMOCLOMIN /00357801/ (View Homoclomin /00357801/ Review and Homoclomin /00357801/ Label ), NEOMALLERMIN TR (View Neomallermin-tr Review and Neomallermin-tr Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

6126361-3 | Cholestasis
on Mar 13, 2009 Male patient from JAPAN , 73 years of age, was treated with Allegra (View Usage). Patient had the following side effects: cholestasis. Allegra dosage: Dose: 60 Mg X 1 Tablet.

6119347-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise
on Mar 11, 2009 Male patient from JAPAN , 24 years of age, was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise. Allegra dosage: .

6103708-5 | Interstitial Lung Disease
Patient was taking Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Feb 27, 2009 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 131.0 lb, was diagnosed with urticaria and. Allegra dosage: . During the same period patient was treated with SHOSEIRYUTO (View Shoseiryuto Review and Shoseiryuto Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), OPIUM ALKALOIDS AND DERIVATIVES (View Opium Alkaloids And Derivatives Review and Opium Alkaloids And Derivatives Label ), EMPYNASE /00521001/ (View Empynase /00521001/ Review and Empynase /00521001/ Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6103707-3 | Cerebrovascular Accident, Muscular Weakness
Adverse event was reported on Feb 26, 2009 by a Female patient taking Allegra (View Usage) (Dosage: ) . Location: UNITED STATES , 67 years of age, Patient had the following side effects: cerebrovascular accident, muscular weakness. During the same period patient was treated with NASACORT AQ (Dose: Unk) (View Nasacort Aq Review and Nasacort Aq Label ). Patient was hospitalized.

6100368-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis Fulminant, Jaundice, Malaise
on Feb 18, 2009 Female patient from JAPAN , 74 years of age, was diagnosed with hypertension and was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis fulminant, jaundice (What is jaundice?), malaise. Allegra dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ).

6096891-1 | Arthralgia, Choking, Hypersensitivity, Myalgia
on Feb 17, 2009 Female patient from JAPAN , 47 years of age, weighting 127.9 lb, was diagnosed with hypertension and was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, choking (What is choking?), hypersensitivity, myalgia. Allegra dosage: . During the same period patient was treated with AMLODIN (View Amlodin Review and Amlodin Label ).

6093493-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis Fulminant, Jaundice, Malaise
Patient was taking Allegra (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis fulminant, jaundice (What is jaundice?), malaise on Feb 18, 2009 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with hypertension and. Allegra dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ).

6092194-X | Granulocytopenia, Hepatic Function Abnormal, White Blood Cell Count Decreased
Adverse event was reported on Feb 17, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: JAPAN , 35 years of age, weighting 148.6 lb, After Allegra was administered, patient had the following side effects: granulocytopenia, hepatic function abnormal, white blood cell count decreased. During the same period patient was treated with SULBACILLIN (View Sulbacillin Review and Sulbacillin Label ), GENTACIN (View Gentacin Review and Gentacin Label ), HANP (View Hanp Review and Hanp Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ).

6083952-6 | Loss Of Consciousness
on Feb 15, 2009 Male patient from JAPAN , 56 years of age, was diagnosed with urticaria, hypertension and was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness. Allegra dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6077202-4 | Arthralgia, Dyspnoea, Myalgia
on Feb 06, 2009 Female patient from JAPAN , 47 years of age, weighting 127.9 lb, was diagnosed with hypertension and was treated with Allegra (View Usage). Patient had the following side effects: arthralgia, dyspnoea, myalgia. Allegra dosage: . During the same period patient was treated with AMLODIN (View Amlodin Review and Amlodin Label ).

6077201-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal, White Blood Cell Count Decreased
Patient was taking Allegra (View Usage). After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, white blood cell count decreased on Feb 06, 2009 from JAPAN Additional patient health information: Male patient , 35 years of age, . Allegra dosage: . Patient was hospitalized.

6075887-X | Lip Oedema, Loss Of Consciousness, Tongue Oedema
Adverse event was reported on Feb 01, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) was diagnosed with urticaria, hypertension and. Location: JAPAN , 56 years of age, Patient experienced the following unwanted or unexpected effects: lip oedema, loss of consciousness, tongue oedema. During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6072092-8 | Alanine Aminotransferase Increased, Hepatic Function Abnormal, Malaise, Nasopharyngitis
on Feb 03, 2009 Female patient from JAPAN , 18 years of age, was treated with Allegra (View Usage). Patient had the following side effects: alanine aminotransferase increased, hepatic function abnormal, malaise, nasopharyngitis. Allegra dosage: .

6062667-4 | Condition Aggravated, Delirium, Dementia, Hallucination, Hallucination, Auditory, Irritability
on Jan 26, 2009 Male patient from JAPAN , 85 years of age, was diagnosed with dementia (What is dementia?) and was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: condition aggravated, delirium, dementia (What is dementia?), hallucination, hallucination, auditory, irritability. Allegra dosage: . During the same period patient was treated with CHINESE HERBAL MEDICINE NOS (View Chinese Herbal Medicine Nos Review and Chinese Herbal Medicine Nos Label ).

6059300-4 | Alanine Aminotransferase Increased, Hepatic Function Abnormal, Malaise, Nasopharyngitis
Patient was taking Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, hepatic function abnormal, malaise, nasopharyngitis on Jan 23, 2009 from JAPAN Additional patient health information: Female patient , 18 years of age, . Allegra dosage: .

6055695-6 | Delirium
Adverse event was reported on Jan 20, 2009 by a Male patient taking Allegra (View Usage) (Dosage: ) . Location: JAPAN , 85 years of age, Patient had the following side effects: delirium.

6045436-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal
on Jan 08, 2009 Male patient from JAPAN , 78 years of age, was treated with Allegra (View Usage). After Allegra was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Allegra dosage: . During the same period patient was treated with LAMISIL (View Lamisil Review and Lamisil Label ).

5988421-7 | Urinary Retention
on Dec 01, 2008 Male patient from JAPAN , 65 years of age, weighting 92.59 lb, was diagnosed with eczema (What is eczema?), epilepsy (What is epilepsy?), subarachnoid haemorrhage, constipation (What is constipation?) and was treated with Allegra (View Usage). Patient experienced the following unwanted or unexpected effects: urinary retention. Allegra dosage: Dose: 60 Mg. During the same period patient was treated with ALEVIATIN (View Aleviatin Review and Aleviatin Label ), GASTER D (View Gaster D Review and Gaster D Label ), PURSENNID /00571901/ (View Pursennid /00571901/ Review and Pursennid /00571901/ Label ), HARNAL (View Harnal Review and Harnal Label ). Patient was hospitalized.

5956201-4 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Chills, Cholestatic Liver Injury, Chromaturia, Eosinophil Count Increased
Patient was taking Allegra (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, cholestatic liver injury, chromaturia, eosinophil count increased on Nov 07, 2008 from UNITED STATES Additional patient health information: Male patient , 34 years of age, was diagnosed with seasonal allergy and. Allegra dosage: Dose: Unk.